RGEN Similar Chart Price Prediction
The price of RGEN is predicted to go up 2.6%, based on the high correlation periods with RERE. The similarity of these two price pattern on the periods is 97.7%.
RGEN
RERE
Up: 2.6%Similarity: 97.7%
RGEN Revenue Forecast
RGEN EPS Forecast
RGEN FAQs
What is bull’s view on RGEN?
What is bear's view on RGEN?
What is RGEN revenue forecast for next quarter？
What is RGEN eps forecast for next quarter？
RGEN Analyst's Forecast
Doug Schenkel
Wolfe Research
Hold
2024-11-14
Price Target
n/a
Downside
0%
Wolfe Research analyst Doug Schenkel initiated coverage of Repligen with a Peer Perform rating and no price target. Bioprocessing tools is currently a $20B market that should return to high-single-digit or low-double-digit growth through 2030, the analyst tells investors in a research note. The firm says Repligen is a unique bioprocessing asset with particular strength in chromatography and filtration. It believes Repligen is positioned well for consistent above-market growth and margin expansion, but says the stock's valuation leaves little room for upside from current levels.
